Belite Bio Inc ADR (BLTE)

Belite Bio Inc ADR (BLTE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.8B; returns 1 day -2.0%, 1 week +3.2%, 1 year +59.8%.

Belite Bio Inc. (BLTE) is a clinical-stage biopharmaceutical company dedicated to developing novel therapeutics for degenerative retinal diseases and metabolic diseases such as nonalcoholic steatohepatitis (NASH) and obesity. Their primary focus is on addressing conditions like Stargardt disease type 1 (STGD1) and geographic atrophy (GA) in advanced dry age-related macular degeneration (AMD).

Groups BLTE belongs to

• Biotechnology
• Clinical Stage Biopharma
• Ophthalmology
• Clinical Stage Biotech
• Pharmaceuticals
• Healthcare
• Life Sciences
• Metabolic Disorders

BLTE financial model: income statement, cash flow and balance sheet